Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Health Catalyst, Inc. (HCAT) had Cost of Goods Sold of $43.18M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$79.41M |
|
$-23.74M |
|
|
Cost of Goods Sold |
$43.18M |
$36.23M |
|
$99.58M |
|
$-20.17M |
|
$-3.36M |
|
$-23.53M |
|
$-23.53M |
|
$-23.74M |
|
$-23.74M |
|
$-23.74M |
|
$-23.74M |
|
$-20.17M |
|
$-6.64M |
|
68.55M |
|
68.55M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$422.72M |
|
$31.65M |
|
$468.83M |
|
$891.54M |
|
$339.56M |
|
$151.29M |
|
$175.17M |
|
$514.73M |
|
$376.81M |
|
$-42.97M |
|
$376.81M |
|
69.48M |
|
| Cash Flow Statement Financials | |
$0.28M |
|
$96.76M |
|
$-4.71M |
|
$249.65M |
|
$341.97M |
|
$92.32M |
|
$7.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.24 |
|
-- |
|
-- |
|
0.29 |
|
1.02 |
|
45.63% |
|
-25.40% |
|
-25.40% |
|
-- |
|
-29.63% |
|
-29.90% |
|
$-5.04M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
1.24 |
|
72.58 |
|
-6.30% |
|
55.25% |
|
-2.66% |
|
-4.50% |
|
$5.42 |
|
$-0.07 |
|
$0.00 |
|